Filter posts

Treating Hepatitis C: Too Costly Not to Act

Today, The Hill published an op-ed – Treating hepatitis C: Too costly not to act …

New Report: Innovation in Hepatitis C Treatment

Today, the California Healthcare Institute released a report on the public health impact of Hepatitis …

Despite Low Funding, Biotech Productivity Remains High In 2013

At the 2013 BIO CEO & Investor Conference, John Milligan, President and COO of Gilead …